Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management Carla Maria Boquimpani; André Neder Ramires Abdo; Denise Pires Martins; Luciana Britto de Abreu Lima; Mayde Seadi Torriani; Israel Bendit;

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study Ana Maria Meireles; Rita Calisto; Maria José Bento; Pedro Martinho Gouveia; Susana Bizarro; Manuel Teixeira; Cláudia Moreira; Ana Espírito Santo; Mário Mariz;

Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;